Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 11 of 11 publications.

Herring WL, Gould IG, Wittrup-Jensen V, Ertle J, Kuti E, Wolowacz S. Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes. J Comp Eff Res. 2022 Dec 1;11(18):1349-63. doi: 10.2217/cer-2021-0194

Carney RSE. Astrocytes function as an intermediate for retrograde endocannabinoid signaling in the suprachiasmatic nucleus to influence circadian clock timing. eNeuro. 2020 Aug 13;7(4):0323-20. doi: 10.1523/ENEURO.0323-20.2020

Carney RSE. Commentary - Pharmacological inactivation of medial prefrontal cortex does not support dichotomous "go/stop" roles for dorsal and ventral subdivisions in natural reward seeking in rats. eNeuro. 2020 Jul 9;7(4):0246-20. doi: 10.1523/ENEURO.0246-20.2020

Carney RSE. Transplanted human induced pluripotent stem cell-derived neurons wire and fire with balanced excitation-inhibition in rat cortex. eNeuro. 2020 Apr 16;7(2):0041-20. doi: 10.1523/ENEURO.0041-20.2020.

Carney RSE. Does prenatal exposure to maternal inflammation causes sex differences in schizophrenia-related behavioral outcomes in adult rats? eNeuro. 2019 Nov 12;6(6):0393-19. doi: 10.1523/ENEURO.0393-19.2019

Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 Aug;7(8):723-35. doi: 10.2217/cer-2018-0003

Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod L, Wolowacz S, Kaye JA, Kontoudis I. Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: a retrospective and prospective observational study (MELABIS). Int J Clin Pract. 2017 May 16;71(5):e12946. doi: 10.1111/ijcp.12946

Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039

Hirsch JD, Gnanasakthy A, Lale R, Choi K, Sarkin AJ. Efficacy of canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures. Int J Clin Pract. 2014 Dec;68(12):1503-7. doi: 10.1111/ijcp.12521

Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang A. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J Clin Pract. 2007 Sep 1;61(9):1437-45.

Berger A, Dukes E, Martin SA, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with FMS. Int J Clin Pract. 2007 Sep 1;61(9):1498-508.